ag 1295 has been researched along with d-64406 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baasner, S; Beckers, T; Böhmer, FD; Botzki, A; Dove, S; Hufsky, H; Kassack, MU; Mahboobi, S; Pongratz, H; Schächtele, C; Sellmer, A; Teller, S; Uberall, F; Uecker, A | 1 |
Böhmer, FD; Cénac, C; Dove, S; Eichhorn, E; Elz, S; Fischer, T; Heidel, F; Höcher, H; Hufsky, H; Mahboobi, S; Pongratz, H; Sellmer, A; Sicker, M; Stocking, C; Trümpler, A; Uecker, A | 1 |
2 other study(ies) available for ag 1295 and d-64406
Article | Year |
---|---|
Bis(1H-2-indolyl)methanones as a novel class of inhibitors of the platelet-derived growth factor receptor kinase.
Topics: Animals; Cell Division; DNA; Enzyme Inhibitors; Glycine; Humans; Indoles; Ketones; Kinetics; Models, Molecular; Molecular Structure; Phosphorylation; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Fibroblast Growth Factor; Receptors, Platelet-Derived Growth Factor; Structure-Activity Relationship | 2002 |
Novel bis(1H-indol-2-yl)methanones as potent inhibitors of FLT3 and platelet-derived growth factor receptor tyrosine kinase.
Topics: Acute Disease; Animals; Antineoplastic Agents; Apoptosis; Binding Sites; Cell Line; Cell Line, Tumor; fms-Like Tyrosine Kinase 3; Humans; In Vitro Techniques; Indoles; Leukemia, Myeloid; Ligands; Mice; Models, Molecular; Phosphorylation; Pyrroles; Receptors, Platelet-Derived Growth Factor; Structure-Activity Relationship | 2006 |